临床预测多药耐药性格拉姆阴性热原性肝和名图结构的临床预测因素:回顾性分析
Ke Xu1, Dong-Hui Wu1, Chu-Jia Zeng1
1Graduate School, Xuzhou Medical University, Xuzhou 221006, Jiangsu Province, China.
World journal of gastroenterology
|November 24, 2025
概括
耐多药格拉姆阴性细菌 (MDR-GNB) 越来越多地导致肝炎性 (PLA). 60岁以上的年龄,糖尿病,恶性瘤,低C-反应蛋白和延长的前列红蛋白时间预测MDR-GNB PLAs,有助于早期的向治疗.
科学领域:
- 传染性疾病 传染性疾病
- 肝病学 肝病学是一种肝病学.
- 微生物学 微生物学
背景情况:
- 发烧性肝 (PLA) 越来越多地是由多抗药性 (MDR) 格拉姆阴性细菌 (GNB) 引起的,特别是Klebsiella pneumoniae和Escherichia coli.
- 这一趋势需要更好地了解MDR-GNB相关PLA的临床特征和风险因素.
研究的目的:
- 确定与MDR-GNB相关的PLA相关的临床特征和风险因素.
- 开发一个预测名录,用于对MDR-GNBPLA进行个性化风险评估.
- 为了提高对PLAs的经验性抗生素选择的及时性.
主要方法:
- 对268名患有格拉姆阴性PLA的患者的回顾性分析,分为MDR (105名患者) 和非耐药 (163名患者) 组.
- 多变量渐进回归建模用于建立基于人口统计,实验室和预后指标的预测名录.
- 统计分析包括独立样本t测试,威尔科克森等级和和测试,以及基平方或费舍尔的精确测试.
主要成果:
- 在PLA中,MDR-GNB占39%,主要是Klebsiella pneumoniae (43%) 和大肠杆菌 (42%).
- 确定了MDR-GNBPLA的独立预测因素是:年龄≥60岁,糖尿病,恶性瘤,较低的C-反应蛋白水平和延长的前列血栓时间.
- 开发了一个名图,将这五个预测因素整合在一起,以进行个性化风险评估.
结论:
- 60岁以上的年龄,糖尿病,恶性瘤,较低的C-反应蛋白和较高的前列血红蛋白时间水平可以预测PLA中的MDR-GNB感染.
- 基于这些因素的早期查可以指导更有针对性的抗生素治疗.
- 需要进一步的多中心,前性研究来验证预测模型的通用性.
更多相关视频
相关概念视频
Acute Pyelonephritis II: Diagnostic Studies and Management
291
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
291
Dosage Regimen Designs: Nomograms and Tabulations
163
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
163
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
170
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
170
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
254
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
254
Acute Pyelonephritis I: Introduction
447
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
447


